100 related articles for article (PubMed ID: 12709424)
1. Myeloid expression of cytochrome P450 4F3 is determined by a lineage-specific alternative promoter.
Christmas P; Carlesso N; Shang H; Cheng SM; Weber BM; Preffer FI; Scadden DT; Soberman RJ
J Biol Chem; 2003 Jul; 278(27):25133-42. PubMed ID: 12709424
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CYP4F3 gene. tissue-specific splicing and alternative promoters generate high and low K(m) forms of leukotriene B(4) omega-hydroxylase.
Christmas P; Ursino SR; Fox JW; Soberman RJ
J Biol Chem; 1999 Jul; 274(30):21191-9. PubMed ID: 10409674
[TBL] [Abstract][Full Text] [Related]
3. Human cytochrome P450 4F3: structure, functions, and prospects.
Corcos L; Lucas D; Le Jossic-Corcos C; Dréano Y; Simon B; Plée-Gautier E; Amet Y; Salaün JP
Drug Metabol Drug Interact; 2012 Apr; 27(2):63-71. PubMed ID: 22706230
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing determines the function of CYP4F3 by switching substrate specificity.
Christmas P; Jones JP; Patten CJ; Rock DA; Zheng Y; Cheng SM; Weber BM; Carlesso N; Scadden DT; Rettie AE; Soberman RJ
J Biol Chem; 2001 Oct; 276(41):38166-72. PubMed ID: 11461919
[TBL] [Abstract][Full Text] [Related]
5. Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells.
Kikuta Y; Yamashita Y; Kashiwagi S; Tani K; Okada K; Nakata K
Biochim Biophys Acta; 2004 Jul; 1683(1-3):7-15. PubMed ID: 15238214
[TBL] [Abstract][Full Text] [Related]
6. Expression and physiological function of CYP4F subfamily in human eosinophils.
Kikuta Y; Mizomoto J; Strobel HW; Ohkawa H
Biochim Biophys Acta; 2007 Dec; 1771(12):1439-45. PubMed ID: 17980168
[TBL] [Abstract][Full Text] [Related]
7. Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells.
Zhang X; Chen L; Hardwick JP
Arch Biochem Biophys; 2000 Jun; 378(2):364-76. PubMed ID: 10860554
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of the rat cytochrome P450 4F5 (CYP4F5) gene.
Cui X; Strobel HW
Gene; 2002 Sep; 297(1-2):179-87. PubMed ID: 12384299
[TBL] [Abstract][Full Text] [Related]
9. Statins increase cytochrome P450 4F3-mediated eicosanoids production in human liver cells: a PXR dependent mechanism.
Plée-Gautier E; Antoun J; Goulitquer S; Le Jossic-Corcos C; Simon B; Amet Y; Salaün JP; Corcos L
Biochem Pharmacol; 2012 Aug; 84(4):571-9. PubMed ID: 22634049
[TBL] [Abstract][Full Text] [Related]
10. CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload.
Madec S; Cerec V; Plée-Gautier E; Antoun J; Glaise D; Salaun JP; Guguen-Guillouzo C; Corlu A
Drug Metab Dispos; 2011 Oct; 39(10):1987-96. PubMed ID: 21778351
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids.
Kalsotra A; Turman CM; Kikuta Y; Strobel HW
Toxicol Appl Pharmacol; 2004 Sep; 199(3):295-304. PubMed ID: 15364545
[TBL] [Abstract][Full Text] [Related]
12. CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis.
Antoun J; Goulitquer S; Amet Y; Dreano Y; Salaun JP; Corcos L; Plée-Gautier E
J Lipid Res; 2008 Oct; 49(10):2135-41. PubMed ID: 18566475
[TBL] [Abstract][Full Text] [Related]
13. Human leukotriene B4 omega-hydroxylase (CYP4F3) gene: molecular cloning and chromosomal localization.
Kikuta Y; Kato M; Yamashita Y; Miyauchi Y; Tanaka K; Kamada N; Kusunose M
DNA Cell Biol; 1998 Mar; 17(3):221-30. PubMed ID: 9539102
[TBL] [Abstract][Full Text] [Related]
14. Induction of CYP4F3 by benzene metabolites in human white blood cells in vivo in human promyelocytic leukemic cell lines and ex vivo in human blood neutrophils.
Zhao Z; He X; Bi Y; Xia Y; Tao N; Li L; Ma Q
Drug Metab Dispos; 2009 Feb; 37(2):282-91. PubMed ID: 19029204
[TBL] [Abstract][Full Text] [Related]
15. A disease-associated missense mutation in CYP4F3 affects the metabolism of leukotriene B4 via disruption of electron transfer.
Smeets E; Huang S; Lee XY; Van Nieuwenhove E; Helsen C; Handle F; Moris L; El Kharraz S; Eerlings R; Devlies W; Willemsen M; Bücken L; Prezzemolo T; Humblet-Baron S; Voet A; Rochtus A; Van Schepdael A; de Zegher F; Claessens F
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2242-2253. PubMed ID: 35686338
[TBL] [Abstract][Full Text] [Related]
16. Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene.
Walsh NC; Cahill M; Carninci P; Kawai J; Okazaki Y; Hayashizaki Y; Hume DA; Cassady AI
Gene; 2003 Mar; 307():111-23. PubMed ID: 12706893
[TBL] [Abstract][Full Text] [Related]
17. Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin.
Cheng PY; Wang M; Morgan ET
J Pharmacol Exp Ther; 2003 Dec; 307(3):1205-12. PubMed ID: 14557382
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cytochrome P450 gene transcription by phenobarbital.
Kemper B
Prog Nucleic Acid Res Mol Biol; 1998; 61():23-64. PubMed ID: 9752718
[TBL] [Abstract][Full Text] [Related]
19. Expression and molecular cloning of human liver leukotriene B4 omega-hydroxylase (CYP4F2) gene.
Kikuta Y; Miyauchi Y; Kusunose E; Kusunose M
DNA Cell Biol; 1999 Sep; 18(9):723-30. PubMed ID: 10492403
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor binding to a putative double E-box motif represses CYP3A4 expression in human lung cells.
Biggs JS; Wan J; Cutler NS; Hakkola J; Uusimäki P; Raunio H; Yost GS
Mol Pharmacol; 2007 Sep; 72(3):514-25. PubMed ID: 17548528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
